Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial
Tan, Antoinette R, Wright, Gail S, Thummala, Anu R, Danso, Michael A, Popovic, Lazar, Pluard, Timothy J, Han, Hyo S, Vojnović, Željko, Vasev, Nikola, Ma, Ling, Richards, Donald A, Wilks, Sharon T, Milenković, Dušan, Yang, Zhao, Antal, Joyce M, Morris, Shannon R, O'Shaughnessy, Joyce
Published in The lancet oncology (01.11.2019)
Published in The lancet oncology (01.11.2019)
Get full text
Journal Article
Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive‐stage small cell lung cancer: A multicentre, randomised, double‐blind, placebo‐controlled Phase II trial
Daniel, Davey, Kuchava, Vladimer, Bondarenko, Igor, Ivashchuk, Oleksandr, Reddy, Sreekanth, Jaal, Jana, Kudaba, Iveta, Hart, Lowell, Matitashvili, Amiran, Pritchett, Yili, Morris, Shannon R., Sorrentino, Jessica A., Antal, Joyce M., Goldschmidt, Jerome
Published in International journal of cancer (15.05.2021)
Published in International journal of cancer (15.05.2021)
Get full text
Journal Article
Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study
Hart, Lowell L., Ferrarotto, Renata, Andric, Zoran G., Beck, J. Thaddeus, Subramanian, Janakiraman, Radosavljevic, Davorin Z., Zaric, Bojan, Hanna, Wahid T., Aljumaily, Raid, Owonikoko, Taofeek K., Verhoeven, Didier, Xiao, Jie, Morris, Shannon R., Antal, Joyce M., Hussein, Maen A.
Published in Advances in therapy (01.01.2021)
Published in Advances in therapy (01.01.2021)
Get full text
Journal Article
Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies
Weiss, Jared, Goldschmidt, Jerome, Andric, Zoran, Dragnev, Konstantin H., Gwaltney, Chad, Skaltsa, Konstantina, Pritchett, Yili, Antal, Joyce M., Morris, Shannon R., Daniel, Davey
Published in Clinical lung cancer (01.09.2021)
Published in Clinical lung cancer (01.09.2021)
Get full text
Journal Article
A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumors
Aghajanian, Carol, Bell-McGuinn, Katherine M., Burris, Howard A., Siu, Lillian L., Stayner, Lee-Ann, Wheler, Jennifer J., Hong, David S., Kurkjian, Carla, Pant, Shubham, Santiago-Walker, Ademi, Gauvin, Jennifer L., Antal, Joyce M., Opalinska, Joanna B., Morris, Shannon R., Infante, Jeffrey R.
Published in Investigational new drugs (01.12.2018)
Published in Investigational new drugs (01.12.2018)
Get full text
Journal Article
Myeloprotective Effects of Trilaciclib Among Patients with Small Cell Lung Cancer at Increased Risk of Chemotherapy-Induced Myelosuppression: Pooled Results from Three Phase 2, Randomized, Double-Blind, Placebo-Controlled Studies
Hussein, Maen, Maglakelidze, Marina, Richards, Donald A, Sabatini, Marielle, Gersten, Todd A, Lerro, Keith, Sinielnikov, Ivan, Spira, Alexander, Pritchett, Yili, Antal, Joyce M, Malik, Rajesh, Beck, J Thaddeus
Published in Cancer management and research (01.01.2021)
Published in Cancer management and research (01.01.2021)
Get full text
Journal Article
Effect of hepatic or renal impairment on the pharmacokinetics of casopitant, a NK-1 receptor antagonist
Bauman, John W., Antal, Joyce M., Adams, Laurel M., Johnson, Brendan M., Murray, Sharon C., Peng, Bin, Kirby, Lyndon C., Lebowitz, Peter F., Marbury, Thomas C., Swan, Suzanne, Gutierrez, Maria
Published in Investigational new drugs (01.04.2012)
Published in Investigational new drugs (01.04.2012)
Get full text
Journal Article
Novel AKT Inhibitor Afuresertib In Combination With Bortezomib and Dexamethasone Demonstrates Favorable Safety Profile and Significant Clinical Activity In Patients With Relapsed/Refractory Multiple Myeloma
Voorhees, Peter M, Spencer, Andrew, Sutherland, Heather J., O'Dwyer, Michael E, Huang, Shang-Yi, Stewart, Keith, Chari, Ajai, Rosenzwieg, Michael, Nooka, Ajay K., Rosenbaum, Cara A, Hofmeister, Craig C, Smith, Deborah A, Antal, Joyce M, Santiago-Walker, Ademi, Gauvin, Jennifer, Opalinska, Joanna B, Trudel, Suzanne
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Amyloid β and Amylin Fibrils Induce Increases in Proinflammatory Cytokine and Chemokine Production by THP‐1 Cells and Murine Microglia
Yates, Stephen L., Burgess, Loyd H., Kocsis‐Angle, June, Antal, Joyce M., Dority, Michael D., Embury, Paula B., Piotrkowski, Anthony M., Brunden, Kurt R.
Published in Journal of neurochemistry (01.03.2000)
Published in Journal of neurochemistry (01.03.2000)
Get full text
Journal Article
Abstract C132: Effect of hepatic or renal impairment on the pharmacokinetics of casopitant
Bauman, John W., Antal, Joyce M., Adams, Laurel M., Johnson, Brendan M., Murray, Sharon C., Kirby, Lyndon C., Lebowitz, Peter F., Peng, Bin, Marbury, Thomas C., Swan, Suzanne, Gutierrez, Maria
Published in Molecular cancer therapeutics (10.12.2009)
Published in Molecular cancer therapeutics (10.12.2009)
Get full text
Journal Article
Characterization of exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses
Thomassen, MJ, Antal, JM, Connors, MJ, Meeker, DP, Wiedemann, HP
Published in American journal of respiratory cell and molecular biology (01.04.1994)
Published in American journal of respiratory cell and molecular biology (01.04.1994)
Get full text
Journal Article
Surfactant suppresses NF-kappa B activation in human monocytic cells
Antal, JM, Divis, LT, Erzurum, SC, Wiedemann, HP, Thomassen, MJ
Published in American journal of respiratory cell and molecular biology (01.04.1996)
Published in American journal of respiratory cell and molecular biology (01.04.1996)
Get full text
Journal Article